Additional survival analysis was conducted by recategorised tumours according to expression of any two of MAP4, Syk-c, Syk-n, calpain-1, -2, -4 and calpastatin into four groups each time; for example, grouping patients into the following four groups (i.e., high Syk-n and high Syk-c; high Syk-n and low Syk-c; low Syk-n and high Syk-c; low Syk-n and low Syk-c). The gene discussed is CAPN1; the disease is neoplasm.